ArticlePharmaceutical science advances2024

Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma.

Yawen Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.